Multi-site Communication Deficits in Schizophrenia
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01317121|
Recruitment Status : Unknown
Verified June 2015 by CMulert, Universitätsklinikum Hamburg-Eppendorf.
Recruitment status was: Recruiting
First Posted : March 17, 2011
Last Update Posted : June 3, 2015
|Condition or disease|
|Study Type :||Observational|
|Estimated Enrollment :||144 participants|
|Observational Model:||Case Control|
|Official Title:||Multi-site Communication Deficits Underlying Cognitive Dysfunction in the Prodromal Phase and First Episode of Schizophrenia|
|Study Start Date :||July 2011|
|Estimated Primary Completion Date :||December 2015|
|Estimated Study Completion Date :||June 2016|
Subjects at risk for psychosis
Identification and clinical characterization of subjects with prodromal symptoms will be done in the early diagnosis outpatient center of the University Department of Psychiatry in Hamburg, Germany. Subjects At Risk Mental State (ARMS) for psychosis will be identified if they meet the criteria of the Structured Interview for Prodromal Syndromes (SIPS) (McGlashan et al 2001).
Patients with a first episode of schizophrenia
Patients with a first episode of schizophrenia will be recruited from inpatients at the Clinic for Psychiatry and Psychotherapy at the University Hospital (UKE) in Hamburg, Germany. All patients have to meet criteria for DSM-IV and ICD-10 diagnosis for schizophrenia.
Healthy control subjects
Healthy control subjects will be recruited from the hospital staff and students at the University Hospital Hamburg-Eppendorf (UKE), Hamburg, Germany. They have to be free from any neurological or psychiatric disorder, according to DSM-IV and ICD-10 criteria.
- Brain function [ Time Frame: baseline and one-year follow-up ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01317121
|Contact: Christoph Mulert, Prof. Dr.||+49 40 7410- ext firstname.lastname@example.org|
|Department of Psychiatry and Psychotherapy, University Hospital Hamburg-Eppendorf (UKE)||Recruiting|
|Hamburg, Germany, 20246|
|Contact: Christoph Mulert, Prof. Dr. +49 40 7410 ext 59520 email@example.com|
|Principal Investigator: Christoph Mulert, Prof. Dr.|
|Sub-Investigator: Gregor Leicht, Dr.|
|Sub-Investigator: Matthias Ertl, Dipl.-Ing.|
|Principal Investigator:||Christoph Mulert, Prof. Dr.||University Medical Center Hamburg-Eppendorf, Department of Psychiatry|